Senior Biomarker Scientist - Translational Medicine

SimplyVision GmbH; Basel; Hybrid; CHF 85,000 - 106,000; Full time

Job summary

SimplyVision GmbH is seeking a Senior Scientist in Biomarker Development, Translational Medicine, based in Basel on a project basis. You will drive exploratory biomarker strategies across clinical programs, developing state-of-the-art assays and collaborating with global experts to support early and clinical development.

The role requires hands-on assay development, validation and data interpretation, with a focus on ligand-binding technologies and LC-MS, in a highly regulated environment.

Qualifications

• BS/MS degree in Biology, Immunology, Cell biology or equivalent field with experience in a pharma/biotech lab.
• Extensive understanding of ligand binding assays; LC-MS knowledge a plus.
• Strong analytical thinking and collaborative teamwork.
• Experience in global organizations and matrix-resourcing is a plus.
• Excellent written and oral communication skills; regulatory knowledge (GCLP, ICH).

Responsibilities

• Hands-on development/validation of soluble biomarker assays (ELISA, MSD, NULISA, Ella, LC-MS).
• Transfer and monitor assays at external providers.
• Generate/interpret biomarker data for mechanism, dose, biology across early programs.
• Ensure timely data delivery from internal/outsourced activities.
• Lead assay strategy, data quality, interpretation and study endpoints alignment.

Skills

Ligand binding assays

Analytical thinking

Teamwork

Global organization experience

Communication skills

Regulatory knowledge (GCLP/ICH)

Education

BS/MS in Biology/Immunology/Cell biology

Job description

SimplyVision GmbH is seeking a Senior Scientist in Biomarker Development, Translational Medicine, based in Basel on a project basis. You will drive exploratory biomarker strategies across clinical programs, developing state-of-the-art assays and collaborating with global experts to support early and clinical development.

The role requires hands-on assay development, validation and data interpretation, with a focus on ligand-binding technologies and LC-MS, in a highly regulated environment.